Management Team


Chelation Partners has a full time staff of 4 PhD and 2 MSc researchers. This staff is supported by a number of research teams at Dalhousie University, McMaster University, the National Research Council of Canada (NRC) labs, teaching hospitals in Halifax, Nova Scotia and CRO’s -- Jubilant Life Sciences, Syngene/Biocon, BioNeeds and Foresight Regulatory Strategies.

Bill Cheliak


Bill has over 20 years of business experience in a wide variety of biotechnology fields, including vaccines, human genetics, drug development, manufacturing and extensive interactions with the pharmaceutical industry. Over the past 15 years, Bill has been involved in business development in the biotechnology sector with both private and publicly traded companies. He has executed numerous technology deals with Pharma, academic institutions and hospitals as well as securing financing ($150M+) with many ventures. Bill currently serves on the Board of Directors of a publicly traded company on the TSX. He has a PhD in Genetics. 

Bruce Holbein


Bruce has Ph.D. in microbiology with over 25 years of both academic and industrial experience in life sciences research and development and commercialization of biotechnologies. He has managed the development and commercialization of environmental and microbial biotechnologies. Bruce pioneered research on the roles of iron in the pathogenesis of bacterial disease with more than 100 publications and 15 patents.

Darrin Campbell


Darrin is a Certified Management Accountant with 20 years of  executive financial management and leadership experience with both public and private companies, focusing on strategic planning, acquisitions, financial controls and reporting.

Please reload